About Robert Friedman
Robert Friedman is an NBO Pharma board member. The company is testing nasal octreotide for idiopathic intracranial hypertension.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Robert Friedman in the role, so the role may have started earlier or lasted longer.
NBO Pharma Inc. Current
Board Member
2026 – Present · Bedford, NY
NBO is testing nasal octreotide as a treatment for idiopathic intracranial hypertension.
Key Colleagues at Startups
The people Robert Friedman works with at each company, as listed on that company's latest Form D.
NBO Pharma Inc. · Form D, Nov 9, 2026
FP
Fredric Price
Chairman & Chief Executive Officer
CF
Colin Foster
Board Member
BG
Bard Geesaman
Board Member